Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ
Market Cap
$607.31M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
110 of 809
Rank in Industry
78 of 445
Largest Insider Buys in Sector
LXRX Stock Price History Chart
LXRX Stock Performance
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Insider Activity of Lexicon Pharmaceuticals, Inc.
Over the last 12 months, insiders at Lexicon Pharmaceuticals, Inc. have bought $1.28M and sold $0 worth of Lexicon Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Lexicon Pharmaceuticals, Inc. have bought $49.6M and sold $158,440 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DEBBANE RAYMOND (director) — $2.21M. COATS LONNEL (Chief Executive Officer) — $296,578. WADE JEFFREY L (President and CFO) — $13,800.
The last purchase of 90,000 shares for transaction amount of $94,797 was made by COATS LONNEL (Chief Executive Officer) on 2023‑11‑16.
List of Insider Buy and Sell Transactions, Lexicon Pharmaceuticals, Inc.
| 2023-11-16 | COATS LONNEL | Chief Executive Officer | 90,000 0.0365% | $1.05 | $94,797 | +66.04% | ||
| 2023-11-10 | COATS LONNEL | Chief Executive Officer | 10,000 0.0041% | $1.01 | $10,100 | +72.33% | ||
| 2023-10-12 | DEBBANE RAYMOND | director | 148,820 0.0604% | $1.03 | $153,805 | +63.46% | ||
| 2023-10-11 | DEBBANE RAYMOND | director | 342,874 0.1415% | $1.08 | $370,784 | +58.88% | ||
| 2023-10-10 | DEBBANE RAYMOND | director | 508,306 0.2365% | $1.14 | $579,367 | +51.79% | ||
| 2023-09-14 | WADE JEFFREY L | President and CFO | 10,000 0.0042% | $1.38 | $13,800 | +20.90% | ||
| 2023-08-04 | McDermott Wendy | VP, Human Resources | 6,000 0.0024% | $1.84 | $11,040 | -12.30% | ||
| 2023-06-29 | COATS LONNEL | Chief Executive Officer | 10,000 0.0053% | $2.16 | $21,600 | -21.20% | ||
| 2023-06-26 | COATS LONNEL | Chief Executive Officer | 10,000 0.0053% | $2.18 | $21,792 | -21.20% | ||
| 2023-06-23 | COATS LONNEL | Chief Executive Officer | 10,000 0.0056% | $2.50 | $24,950 | -27.85% | ||
| 2023-06-23 | McDermott Wendy | VP, Human Resources | 10,000 0.0054% | $2.43 | $24,300 | -27.85% | ||
| 2023-06-22 | COATS LONNEL | Chief Executive Officer | 40,000 0.0211% | $2.31 | $92,400 | -26.08% | ||
| 2023-06-20 | WADE JEFFREY L | President and CFO | 12,000 0.0063% | $2.33 | $28,000 | -27.12% | ||
| 2023-06-05 | Artal International S.C.A. | 27.78M 15.0418% | $2.60 | $72.22M | -32.28% | |||
| 2022-08-05 | Invus Advisors, L.L.C. | 2.43M 1.2253% | $2.50 | $6.07M | -18.02% | |||
| 2022-08-05 | DEBBANE RAYMOND | 147,390 0.0744% | $2.50 | $368,475 | -18.02% | |||
| 2022-08-01 | Invus Advisors, L.L.C. | 16.17M 9.7545% | $2.50 | $40.43M | -2.11% | |||
| 2022-08-01 | DEBBANE RAYMOND | 1.97M 1.1852% | $2.50 | $4.91M | -2.11% | |||
| 2021-03-15 | Sale | Tessmer James F | VP, Finance & Accounting | 22,912 0.0161% | $6.92 | $158,440 | -35.08% | |
| 2020-12-16 | Invus Public Equities, L.P. | 10.94M 9.4404% | $3.20 | $35M | +59.57% |
Insider Historical Profitability
<0.0001%
| DEBBANE RAYMOND | director | 1340847 0.5475% | $1.68 | 7 | 0 | <0.0001% |
| COATS LONNEL | Chief Executive Officer | 914359 0.3733% | $1.68 | 12 | 0 | <0.0001% |
| WADE JEFFREY L | President and CFO | 264341 0.1079% | $1.68 | 3 | 0 | <0.0001% |
| McDermott Wendy | VP, Human Resources | 28478 0.0116% | $1.68 | 2 | 0 | <0.0001% |
| Ulys, LLC | 10 percent owner | 135327888 55.2528% | $1.68 | 4 | 0 | <0.0001% |
| Artal International S.C.A. | 78634381 32.1055% | $1.68 | 4 | 0 | +10.29% | |
| Invus Advisors, L.L.C. | 50859331 20.7653% | $1.68 | 2 | 0 | <0.0001% | |
| Invus Public Equities, L.P. | 32259461 13.1712% | $1.68 | 27 | 0 | <0.0001% | |
| Invus C.V. | 30248505 12.3501% | $1.68 | 3 | 0 | +21.63% | |
| SANDS ARTHUR T | Pres & CEO | 682662 0.2787% | $1.68 | 0 | 4 | |
| SOBECKI CHRISTOPHER J | director | 137293 0.0561% | $1.68 | 2 | 0 | <0.0001% |
| ZAMBROWICZ BRIAN P | EVP, Research | 101600 0.0415% | $1.68 | 0 | 2 | |
| Tessmer James F | VP, Finance & Accounting | 71766 0.0293% | $1.68 | 1 | 4 | +91.67% |
| BARKER SAM L | director | 52187 0.0213% | $1.68 | 4 | 0 | +14.18% |
| GREGORY JULIA P | EVP, Corp Dev and CFO | 50200 0.0205% | $1.68 | 0 | 6 | |
| Mills Barry | director | 25000 0.0102% | $1.68 | 1 | 0 | <0.0001% |
| ROSE CLAYTON STUART | director | 25000 0.0102% | $1.68 | 2 | 0 | <0.0001% |
| Santini Alexander A | EVP and CCO | 18661 0.0076% | $1.68 | 2 | 0 | <0.0001% |
| RIGGS RANDALL B | SVP, Corp Licensing | 15000 0.0061% | $1.68 | 0 | 2 | |
| CASKEY C THOMAS | director | 6300 0.0026% | $1.68 | 5 | 0 | +5.92% |
| NIES ALAN S | director | 5000 0.002% | $1.68 | 1 | 0 | <0.0001% |
| PERSON CHRISTOPHE | VP Informatics | 0 0% | $1.68 | 0 | 2 | |
| PIGGOTT JAMES R PHD | SVP of Pharm Bio | 0 0% | $1.68 | 0 | 5 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Artal Group S A | $282.13M | 32.52 | 117.55M | 0% | +$0 | 1.5 | |
| Fidelity Investments | $33.35M | 3.84 | 13.89M | +510.33% | +$27.88M | <0.01 | |
| BlackRock | $18.46M | 2.13 | 7.69M | +9.82% | +$1.65M | <0.0001 | |
| The Vanguard Group | $15.36M | 1.77 | 6.4M | +7.04% | +$1.01M | <0.0001 | |
| OrbiMed | $8.5M | 0.98 | 3.54M | New | +$8.5M | 0.17 | |
| Geode Capital Management | $5.73M | 0.66 | 2.39M | +1.71% | +$96,543.16 | <0.01 | |
| Nea Management Company Llc | $5.72M | 0.66 | 2.38M | 0% | +$0 | 0.07 | |
| State Street | $4.77M | 0.55 | 1.99M | +5.03% | +$228,458.40 | <0.0001 | |
| Pinnacle Associates, Ltd. | $4.19M | 0.48 | 1.75M | +0.98% | +$40,821.60 | 0.07 | |
| Bvf Inc Il | $4.05M | 0.47 | 1.69M | -93.1% | -$54.6M | 0.03 | |
| Ameriprise Financial | $3.4M | 0.39 | 1.42M | -24.98% | -$1.13M | <0.01 | |
| Cubist Systematic Strategies | $3.37M | 0.39 | 1.4M | New | +$3.37M | 0.03 | |
| Schonfeld Group | $5.35M | 0.27 | 960,150 | New | +$5.35M | 0.04 | |
| Charles Schwab | $2.11M | 0.24 | 881,123 | +1.96% | +$40,675.20 | <0.0001 | |
| Northern Trust | $2.08M | 0.24 | 866,556 | +0.81% | +$16,723.21 | <0.0001 | |
| Wellington Management Company | $1.65M | 0.19 | 686,418 | New | +$1.65M | <0.0001 | |
| Point72 Asset Management | $1.4M | 0.16 | 584,386 | New | +$1.4M | <0.01 | |
| Millennium Management LLC | $1.28M | 0.15 | 534,184 | -67.29% | -$2.64M | <0.01 | |
| Nuveen | $1.26M | 0.15 | 524,177 | +27.52% | +$271,514.44 | <0.0001 | |
| Marshall Wace | $1.2M | 0.14 | 499,172 | New | +$1.2M | <0.01 | |
| ExodusPoint Capital Management, LP | $766,000.00 | 0.09 | 319,058 | New | +$766,000.00 | 0.01 | |
| Virtus ETF Advisers LLC | $703,421.00 | 0.08 | 293,092 | +16.81% | +$101,205.63 | 0.19 | |
| Gsa Capital Partners Llp | $704,000.00 | 0.08 | 293,333 | -62.4% | -$1.17M | 0.06 | |
| BNY Mellon | $700,815.00 | 0.08 | 292,006 | -14.39% | -$117,770.50 | <0.0001 | |
| Jane Street Capital | $675,811.00 | 0.08 | 281,588 | +3.39% | +$22,130.39 | <0.01 | |
| Boulder Hill Capital Management Lp | $615,360.00 | 0.07 | 256,400 | New | +$615,360.00 | 0.25 | |
| Morgan Stanley | $586,101.00 | 0.07 | 244,209 | -73.39% | -$1.62M | <0.0001 | |
| AllianceBernstein | $527,858.00 | 0.06 | 219,941 | -10.34% | -$60,863.95 | <0.0001 | |
| Two Sigma | $454,634.00 | 0.05 | 189,431 | -6.63% | -$32,294.37 | <0.01 | |
| UBS | $400,707.00 | 0.05 | 166,961 | -1.56% | -$6,372.01 | <0.0001 | |
| Goldman Sachs | $374,914.00 | 0.04 | 156,214 | -33.62% | -$189,900.20 | <0.0001 | |
| Citadel Advisors LLC | $322,745.00 | 0.04 | 134,477 | -82.89% | -$1.56M | <0.0001 | |
| RhumbLine Advisers | $323,623.00 | 0.04 | 134,845 | +3.5% | +$10,929.43 | <0.0001 | |
| T. Rowe Price | $253,000.00 | 0.03 | 105,315 | +4.59% | +$11,108.31 | <0.0001 | |
| Compagnie Lombard Odier Scma | $225,600.00 | 0.03 | 94,000 | 0% | +$0 | <0.01 | |
| JPMorgan Chase | $216,326.00 | 0.03 | 90,136 | -97.04% | -$7.09M | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $215,911.00 | 0.03 | 89,963 | +104.49% | +$110,325.50 | <0.0001 | |
| Natixis Advisors L P | $207,000.00 | 0.02 | 86,094 | New | +$207,000.00 | <0.0001 | |
| Bank of America | $206,092.00 | 0.02 | 85,872 | -59.25% | -$299,646.04 | <0.0001 | |
| Barclays | $155,000.00 | 0.02 | 64,619 | -49.13% | -$149,670.14 | <0.0001 | |
| Stifel | $125,217.00 | 0.01 | 52,174 | +31.58% | +$30,052.66 | <0.0001 | |
| Russell Investments Group Ltd | $117,840.00 | 0.01 | 49,100 | 0% | +$0 | <0.0001 | |
| Dimensional Fund Advisors | $119,863.00 | 0.01 | 49,943 | New | +$119,863.00 | <0.0001 | |
| Invesco | $119,564.00 | 0.01 | 49,818 | -18.57% | -$27,273.78 | <0.0001 | |
| Lazard Freres Gestion S A S | $119,000.00 | 0.01 | 50,000 | New | +$119,000.00 | <0.01 | |
| American International Group | $109,579.00 | 0.01 | 45,658 | -0.85% | -$938.40 | <0.0001 | |
| China Universal Asset Management Co., Ltd. | $112,632.00 | 0.01 | 46,930 | +65.66% | +$44,642.40 | 0.01 | |
| Wedbush Securities Inc | $100,000.00 | 0.01 | 41,650 | New | +$100,000.00 | <0.01 | |
| Virtu Financial Llc | $105,000.00 | 0.01 | 43,591 | New | +$105,000.00 | 0.01 | |
| Kwb Wealth | $97,536.00 | 0.01 | 40,640 | 0% | +$0 | 0.01 |